A Cold the Week Before Surgery: Why the Airway Is Still Reactive After the Symptoms Are Gone, and How Long the Postponement Actually Needs to Be

The pre-operative phone call the night before surgery asks about fasting, medications, and a ride home. It usually also asks whether the patient has been sick. The answer to that last question is the one most often shaded, because the patient has spent months and a nonrefundable deposit getting to this date, and because a scratchy throat does not feel like a reason to give any of that back. So the patient says they are fine, arrives with a decongestant in their system, and the anesthesiologist finds out in the holding area, with the operating room booked and the surgeon scrubbed, that the patient has been coughing for a week.

What happens next depends on the facility, and that variability is the problem. Some practices cancel on the spot. Some proceed because the case is under local anesthesia with sedation and the airway will not be instrumented. Some proceed because cancelling costs the surgeon the day. The medical question underneath all of this has a reasonably clear answer, and it has been studied for fifty years, almost entirely in children, with a large recent addition from the pandemic. The answer is not "a cold does not matter." It is "a cold matters for a specific reason, for a specific period, and the period is longer than the symptoms."

What a respiratory infection does to the airway under anesthesia

The short answer: a viral infection of the upper airway makes the larynx and bronchi hyperreactive to any stimulus, and under general anesthesia the stimuli are constant, so the rate of laryngospasm, bronchospasm, and oxygen desaturation rises by a factor of two to seven.

The mechanism is not the mucus. It is the nerve. Viral infection strips the respiratory epithelium and exposes the sensory nerve endings underneath, and it shifts the balance of the airway's reflex control toward constriction. The result is an airway that closes hard in response to things that would ordinarily produce nothing: a suction catheter, a breathing tube passing the vocal cords, a bit of secretion on the larynx during emergence, or the volatile anesthetic gas itself. Laryngospasm, the forceful closure of the vocal cords, is the event anesthesiologists worry about most, because it stops air movement entirely until it is broken with positive pressure, a muscle relaxant, or a re-intubation. In the general population it occurs in roughly one in a thousand anesthetics. In a patient with an active or recent upper respiratory infection the pediatric series report it at several times that rate, alongside comparable increases in bronchospasm, breath-holding, and desaturation below 90 percent.

The reason almost all of this evidence comes from children is that children get eight to ten colds a year and have small airways, which made them the population where the question was urgent and the events were frequent enough to count. Alan Tait and Shobha Malviya at the University of Michigan published the foundational work in Anesthesiology in 2001, following more than a thousand children through surgery with and without active or recent respiratory symptoms, and found that the independent predictors of an airway event were an endotracheal tube, a history of reactive airway disease, parental smoking, and, crucially, the presence of copious secretions and nasal congestion rather than the mere history of a cold. The adult data are thinner, because adults are less often studied while sick, but the physiology does not change at eighteen. An adult with a productive cough has the same exposed airway nerves and the same reflex arc, and a longer, more complicated operation to get through.

The number that matters most for scheduling is not the risk during the infection. It is how long the risk persists afterward. A study of adults with ordinary viral colds published in the American Review of Respiratory Disease as early as 1976 showed that bronchial hyperreactivity to a histamine challenge lasted up to six weeks after the symptoms had cleared. Subsequent pediatric work has repeatedly confirmed that airway complication rates remain elevated for two to four weeks, and in some series six, after the patient feels well. That is the entire basis for the postponement rules, and it is the part patients are never told: the reason to cancel is not that you have a cold today, it is that the airway you will bring to the operating room in ten days is still the airway of someone who had one.

Which symptoms cancel a case and which do not

The short answer: a clear runny nose without fever, cough, or chest findings is generally acceptable to proceed with, while fever, a productive or wheezy cough, or any lower respiratory sign is a postponement of at least two to four weeks, and the decision belongs to the anesthesiologist, not the surgeon.

Anesthesiology has never produced a rigid protocol here, because the evidence does not support one, and the honest guidance from bodies like the American Society of Anesthesiologists is that the decision rests on clinical judgment weighted by a few variables. The variables are consistent across the literature. On the patient's side: fever, the color and volume of secretions, whether the cough is dry or productive, whether there is wheezing or crackles on the chest, and whether the patient smokes or has asthma. On the anesthetic side: whether the airway will be instrumented at all, whether with an endotracheal tube or a supraglottic device, and how long the case will run. A pediatric scoring tool published in 2014, the COLDS score, formalizes this by adding up current symptoms, onset timing, lung disease, airway device, and type of surgery, and it maps cleanly onto how adult anesthesiologists actually think.

A useful way to sort the cases:

• Proceed: clear nasal discharge, mild sore throat, no fever, no cough, lungs clear, no asthma or smoking history. This is the "common cold" of the textbooks and it is the one Tait and Malviya's data suggest does not meaningfully raise risk, especially if the airway is managed with a mask or a laryngeal mask rather than a tube.
• Postpone two to four weeks: any fever, purulent or copious secretions, a productive cough, wheezing on examination, or a patient who "feels sick" as opposed to "has a runny nose." The infection has moved beyond the nose, and the airway will be reactive for weeks after it resolves.
• Postpone four to six weeks or longer: influenza, a lower respiratory infection, anything that required antibiotics or steroids, or any of the above in a smoker, an asthmatic, or a patient with obstructive sleep apnea, who already has a compromised airway and less reserve to tolerate a spasm.

Two things about the timing deserve emphasis. First, "two weeks" is measured from symptom resolution, not from onset, so a patient who cancels on the first day of a cold that lasts ten days is realistically looking at three to four weeks. Second, the type of airway management changes the arithmetic. A supraglottic airway, the laryngeal mask that sits above the vocal cords, produces markedly fewer airway events in sick patients than an endotracheal tube, and a case done under intravenous sedation with the patient breathing spontaneously, the way much awake liposuction and some facial work is done, involves no instrumentation at all. That does not make the cold irrelevant, because a coughing, congested patient is also a poor candidate for sedation and a poor operative field, but it does change the category of risk.

"

The reason to cancel is not that you have a cold today. It is that the airway you bring to the operating room in ten days will still be the airway of someone who had one.

"

What the pandemic added: the COVID timeline and where it came from

The short answer: the largest study ever done on surgery after a respiratory infection found that mortality after elective operations stayed elevated for six weeks after a COVID diagnosis and returned to baseline only at seven weeks, and the resulting guidance sets waits of two to twelve weeks depending on how sick the patient was.

Before 2020 the question of surgery after a respiratory infection had never been studied at scale in adults. The pandemic changed that by accident. The COVIDSurg Collaborative, an international consortium, published in Anaesthesia in 2021 an analysis of more than 140,000 patients across 116 countries who had surgery in the fall of 2020, comparing 30-day mortality by the interval since a COVID diagnosis. Patients operated on within two weeks of diagnosis had roughly four times the mortality of patients without infection. The excess persisted at three to four weeks and at five to six weeks, and only at seven weeks or more did the risk return to the baseline of uninfected patients. Patients who still had symptoms at seven weeks remained at elevated risk even beyond that point. The mechanism was not only the airway; it was pulmonary complications broadly, including pneumonia and respiratory failure, and a thrombotic tendency that any surgeon following the venous thromboembolism data would recognize.

That study is the basis for the joint statement from the American Society of Anesthesiologists and the Anesthesia Patient Safety Foundation on the timing of elective surgery after COVID infection, updated in 2022 and still the reference most facilities use. Its intervals are graded by severity:

• Two weeks for a patient who was asymptomatic or had mild symptoms and did not need hospital care.
• Four weeks for a symptomatic patient who recovered at home.
• Six weeks for a patient who was hospitalized, or who has diabetes, is immunocompromised, or was symptomatic but did not require hospital care and still has residual symptoms.
• Twelve weeks for a patient who needed intensive care.

The statement also says something cosmetic surgery should hear directly: these are minimums, the patient should have returned to their pre-infection functional baseline before proceeding, and the calculation is different for an operation that has no medical urgency. A hernia repair can justify accepting some residual risk at four weeks. A facelift cannot, because there is nothing on the other side of the ledger. As the variant landscape has shifted toward milder disease the pressure to shorten these intervals has grown, and some facilities now treat a mild case like a common cold. That is a defensible reading of the current picture for an asymptomatic patient at two weeks. It is not a defensible reading for someone who was in bed with a fever ten days ago, and the pre-operative testing visit is where that history needs to be taken honestly rather than at the door of the operating room.

The risks that have nothing to do with the airway

The short answer: a respiratory infection also compromises the operation itself, because coughing strains fresh incisions and plications, nasal inflammation ruins a rhinoplasty field, fever confuses the postoperative picture, and the over-the-counter remedies patients take to hide symptoms carry their own anesthetic and bleeding problems.

Anesthesiologists own the airway question, but surgeons have reasons of their own to postpone, and they are procedure-specific. An abdominoplasty with rectus plication depends on that midline repair holding while the tissues heal, and a week of hard coughing in the first days after surgery is a direct mechanical load on it, along with the incision. The same cough drives up venous pressure in the head and neck, which is why a facelift surgeon does not want a coughing patient in the first 48 hours, when hematoma risk is at its peak, and why blood pressure control in that window is treated so seriously. Coughing and retching after a breast augmentation stress the pocket. Any of these can turn a clean case into a return to the operating room.

Rhinoplasty is a special case in the opposite direction. The nasal mucosa during a cold is swollen, friable, and bleeds more, the surgeon cannot assess the internal anatomy against the patient's baseline, and the postoperative edema that already takes a year to settle starts from a worse position. Most rhinoplasty surgeons will not operate through an active cold regardless of what the anesthesiologist says. Fever adds a further problem: a patient who runs a temperature after surgery is worked up for a surgical cause, and a pre-existing viral infection makes that workup harder to interpret and more likely to end in unnecessary antibiotics. A systemic viral illness with fever is also one of the classic triggers for herpes reactivation, which matters for any patient having resurfacing or perioral work.

Then there is the medicine cabinet. Patients trying to get through the pre-operative screen take things. Pseudoephedrine and phenylephrine are sympathomimetics that raise blood pressure and heart rate and interact with the vasoactive drugs used during anesthesia. Many combination cold products contain ibuprofen or aspirin, which most surgeons stop for one to two weeks before an operation because of bleeding, and which the patient does not think of as "a blood thinner" because it came in a box labeled for sinus pressure. Dextromethorphan interacts with several common antidepressants. First-generation antihistamines add to sedation. None of these will show up on a medication reconciliation unless the practice asks specifically, and none of them are the reason a practice tells patients to stop supplements two weeks out, which is a separate stop list that patients tend to follow more carefully than the one for cold medicine.

Why the incentives point the wrong way, and what a good practice does about it

The short answer: everyone at the table loses money when a case is cancelled the morning of surgery, which means the honest version of this conversation has to be built into the process weeks in advance rather than left to a sick patient and a scrubbed surgeon.

Day-of-surgery cancellation for a respiratory infection is among the most common reasons an elective case gets pulled, and in a cosmetic practice it is an expensive event on every side. The patient has arranged time off work, childcare, a caregiver, sometimes travel, and has paid a deposit. The surgeon has an operating day that cannot be refilled. The facility has staff and an anesthesia team booked, and in an accredited outpatient facility an empty room still costs what a full one does. The anesthesiologist, who is the person with the training and the authority to make the call, is often the only one at the table with no financial stake in proceeding, which is precisely why the decision should be theirs and why a practice that lets the surgeon or the office manager override it has its structure backwards. The cost breakdown a patient receives before booking should say, in writing, what a medical postponement costs, and the correct number for a documented illness is close to zero.

The practices that handle this well do three things. They tell the patient at the consultation, months out, that a cold or fever in the two weeks before surgery means a reschedule, so that the news is not new when it arrives. They make the phone call or pre-operative visit a real screen, asking specifically about cough, fever, sore throat, sinus congestion, and sick contacts, and asking what over-the-counter products the patient has taken in the last week. And they make the postponement cheap enough that the patient has no reason to hide anything. A practice that does all three is rarely surprised in the holding area. A practice that does none of them is surprised regularly, and blames the patient.

It helps to be clear-eyed about what the patient is being asked to trade. A postponement of three weeks is a real cost: another round of scheduling, another delay on a result they have wanted for a year. Against that stands a complication that is uncommon but not rare, that happens in the first minutes of an operation with no medical purpose, and that, in the case of laryngospasm in a patient with a full airway of secretions, can escalate to aspiration, an emergency re-intubation, or a hypoxic event. No patient looking at that trade with the numbers in front of them chooses to go ahead with a fever. The trick is that the numbers are almost never in front of them, and the person holding them is usually the last one to see the patient before the operation.

The honest summary

A cold before cosmetic surgery is not a minor detail, and the reason is not the cold. Viral respiratory infection leaves the airway hyperreactive for two to six weeks after the symptoms are gone, and under general anesthesia that hyperreactivity shows up as laryngospasm, bronchospasm, and desaturation at several times the baseline rate. The evidence comes mostly from children, but the physiology is the same in adults, and the pandemic supplied the largest adult dataset ever collected on the subject: mortality after elective surgery stayed elevated for six weeks after a COVID diagnosis and normalized at seven.

The rules that follow are not complicated. A clear runny nose with no fever, cough, or chest findings can generally proceed, particularly if the airway is not going to be intubated. Fever, a productive cough, wheezing, or a patient who feels ill is a postponement of two to four weeks from the end of symptoms, longer for influenza, lower respiratory infection, smokers, asthmatics, and sleep apnea. After COVID, the ASA and APSF intervals run from two weeks for an asymptomatic case to twelve for one that needed intensive care, and for an operation with no medical urgency the longer end of each range is the right reading.

The airway is only half the argument. Coughing loads fresh incisions and plications, raises the hematoma risk after a facelift, and ruins a rhinoplasty field, and the products patients take to hide their symptoms bring blood pressure and bleeding problems of their own. All of this is manageable if the practice has told the patient in advance what illness means for the date, asks the right questions before the morning of surgery, and does not charge people for being honest. The patient's job is to answer the question truthfully. The practice's job is to make sure the truth is not expensive.